Re: Farmas USA
Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2015
GAITHERSBURG, Md., Nov. 02, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced it will report its third quarter 2015 financial and operating results before the open of U.S. financial markets on Monday, November 9, 2015.
In addition, management will host a conference call to discuss the quarterly results and provide an update on corporate activities.
http://ir.novavax.com/phoenix.zhtml?c=71178&p=irol-newsArticle_Print&ID=2105445